Is Fixed-Duration Therapy the New Standard of Care in Frontline CLL?Rodrick Babakhanlou,Alessandra FerrajoliCLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）引用 0|浏览3暂无评分关键词CLL, BTK inhibitors, BCL-2 inhibitors, targeted therapy, first-line therapyAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
